Viela Bio

General Information
Business:

 

We are a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, which we collectively refer to as autoimmune diseases. Our approach seeks to redefine the treatment of autoimmune diseases by focusing on critical biological pathways shared across multiple diseases.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 80
Founded: 2017
Contact Information
Address One MedImmune Way, First Floor, Area Two, Gaithersburg, MD 20878, US
Phone Number (240) 558-0038
Web Address http://www.vielabio.com
View Prospectus: Viela Bio
Financial Information
Market Cap $943.67mil
Revenues $20.0 mil (last 12 months)
Net Income $-57.2 mil (last 12 months)
IPO Profile
Symbol VIE
Exchange NASDAQ
Shares (millions): 7.9
Price range $19.00 - $19.00
Est. $ Volume $150.1 mil
Manager / Joint Managers Goldman Sachs/ Morgan Stanley/ Cowen
CO-Managers Guggenheim Securities
Expected To Trade: 10/3/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change